To evaluate RA-1, a standardized plant extract formulation,
traditionally considered a safe, effective antiarthritic
in the Asian-Indian Ayurvedic medicinal system.
Methods. One hundred eighty-two patients with active-on-chronic
rheumatoid arthritis(RA) participated in a 16 week randomized,
double blind, placebo controlled, parallel efficacy
clinical drug trial in Pune , India. Tenderness, pain,
swelling, and several other efficacy measures were assessed
1. ACR core set 20% and 50% improvement;
2. ACR 20% improvement response. An intent –to-treat
analysis was performed: p < 0.05 considered significant.